Formulary & Prior Auth Guide · Last verified
Does CVS Caremark Cover Foundayo?
By The RX Index Editorial Team · a pricing intelligence and comparison resource for GLP-1 telehealth providers · Last verified:
Some links below are affiliate links. If you use them, we may earn a commission at no extra cost to you. It never changes your price — and it never changes our answer. We check coverage facts against CVS Health, CVS Caremark, CMS, and Eli Lilly directly.
Does CVS Caremark cover Foundayo? Short answer: it can now — but “CVS Caremark covers it” is not the same as “your plan covers it.” On June 1, 2026, CVS Caremark removed its automatic block on Foundayo (Eli Lilly’s new weight-loss pill), so plans are allowed to cover it — though plan sponsors can still customize or exclude that coverage. Whether you get it comes down to three things: did your specific employer or plan turn Foundayo on, does your plan cover weight-loss drugs at all, and do you clear the prior-authorization bar.
Here’s what most pages skip: CVS Caremark has already published the exact medical checklist your doctor has to clear for Foundayo. We read it at the source (ref. 7433-C). Further down you’ll see the real BMI numbers, the 6-month rule, the trap that catches people who already lost weight, and the baseline-BMI fix that turns a preventable denial into a clean approval.
Will CVS Caremark cover your Foundayo? Find your row
CVS Caremark is a pharmacy benefit manager (PBM) — not your insurance company. A PBM is the company your employer or health plan hires to run the prescription side of your benefits and decide which drugs land on the formulary (the plan’s list of covered drugs). When the news says “CVS Caremark will cover Foundayo,” it means Foundayo is now allowed on the menu your plan can pick from. Your plan still has to order it.
| Your situation | CVS cover Foundayo for you? | What you’ll likely pay | Your next move |
|---|---|---|---|
| Commercial (job/marketplace) plan via CVS Caremark that covers weight-loss drugs, and you meet the PA rules | Likely yes — your plan can cover it now | As low as $25/mo with the Foundayo Savings Card | Confirm your plan covers weight-loss drugs, then have your prescriber submit the prior authorization |
| Commercial plan via CVS Caremark that excludes weight-loss drugs | No — a plan exclusion beats everything else | ~$149–$349/mo self-pay | Ask HR if obesity coverage can be added at open enrollment; otherwise use self-pay |
| CVS Caremark plan, not sure if weight-loss is covered | Depends — you won't know until you check | Unknown until verified | Call the number on your card, or run a free coverage check |
| Medicare Part D (any PBM, including CVS Caremark) | Not through normal Part D — but yes via the Medicare GLP-1 Bridge from July 1, 2026 | $50/mo flat through the Bridge | Confirm you meet the BMI rules now; your prescriber can file on or after July 1, 2026 |
| Medicaid managed by CVS Caremark | Varies by state — many states limit or exclude weight-loss GLP-1s | State-dependent | Check your state's Medicaid GLP-1 policy (the savings card can't be used) |
| Uninsured / your plan doesn't cover it | No plan to bill | ~$149–$349/mo self-pay | Use the LillyDirect/Ro self-pay route |
Prices verified against CVS Health, CMS, Eli Lilly, and Ro. They shift as plans add Foundayo — re-check before you commit.
The single biggest thing standing between you and a $25 copay isn’t your dose. It’s whether your plan covers weight-loss medicine at all. That’s the question to answer first — and you don’t have to guess at it.
Check your coverage before you pay a dollar
Ro runs a free GLP-1 Insurance Coverage Checker — you enter your insurance info, Ro checks your benefits, and sends back a personalized coverage report. No commitment, no prescription at this step.
Check whether your plan covers Foundayo — free → (sponsored affiliate link, opens in a new tab)Ro GLP-1 Coverage Checker — sponsored, opens in a new tab.
✅ What we actually verified (checked )
We went to the primary sources — including the June 1, 2026 CVS/Aetna plan drug guide and CVS Caremark’s own Foundayo prior-authorization document.
- ✓CVS Caremark removed the "new-to-market block" on Foundayo on June 1, 2026 — "where approved for coverage by plans," and plan sponsors keep the right to customize coverage. (CVS Health, May 28, 2026.)
- ✓CVS Caremark's Foundayo prior-authorization rules (BMI thresholds, 6-month program, renewal rules, quantity limits, approval length) — from CVS's own Foundayo PA document, reference 7433-C, April 2026.
- ✓CVS/Aetna plan guides state plainly that a plan "may not cover certain drugs to treat conditions such as… weight loss." (2026 CVS/Aetna Standard Control Plan drug guide, updated June 1, 2026.)
- ✓Wegovy stays CVS Caremark's preferred GLP-1; Zepbound returns as an additional preferred option October 1, 2026 for plans that elect it. (CVS Health; CNBC.)
- ✓With a covered commercial plan and the savings card, eligible patients may pay as little as $25/month. The card is commercial-only — not Medicare, Medicaid, TRICARE, or VA. (Eli Lilly; Ro.)
- ✓Medicare's GLP-1 Bridge covers all Foundayo formulations at a flat $50/month from July 1, 2026 through December 31, 2027. (CMS.)
- ✓Self-pay runs about $149/month at the starting dose, up to about $349 at the top dose. (Eli Lilly / LillyDirect; Ro.)
What we could not verify: your personal account, your employer’s exact benefit, your copay, or whether your prior authorization will be approved.
When did CVS Caremark start covering Foundayo?
CVS Caremark lifted its “new-to-market block” on Foundayo on June 1, 2026, for plans that choose to cover it. A new-to-market block is a temporary hold a PBM puts on a brand-new drug while it negotiates the price — during the block, the drug is automatically not covered just for being new. CVS announced this on May 28, 2026, in the same update that brings Zepbound back as an additional preferred option on October 1, 2026.
The fine print the headlines skipped
CVS Caremark’s commercial formularies are templates that millions of people fall under, but employers and health plans make the final call, and they keep the right to customize or exclude coverage. A drug being on the standard template does not guarantee it’s live for every member. The door opened June 1, but your plan still has to walk through it — and some won’t.
One quick correction worth making: Foundayo is a once-a-day pill, not a weekly one. You take it once daily, any time of day, with or without food. (FDA; Eli Lilly.)
The 3 things that actually decide whether you get covered
Your real answer depends on three layers, in order: did your plan turn Foundayo on, does your plan cover weight-loss drugs at all, and do you clear prior authorization. All three have to line up. A lot of people who get denied actually fail on layer two, not layer three.
Gate 1 — Did your plan adopt Foundayo?
The June 1 block lift gave plans permission, not a mandate. CVS/Aetna formulary lists update the first week of each month, so a plan that doesn’t show Foundayo today might show it next month.
Gate 2 — Does your plan cover weight-loss drugs at all?
This is the quiet dealbreaker. Many employers carve out weight-loss medicine to save money. CVS-family plan documents say it plainly: your plan “may not cover certain drugs to treat conditions such as infertility, erectile dysfunction and weight loss.” If your plan has that exclusion, no prior authorization fixes it — the benefit simply isn’t there.
Gate 3 — Do you meet the prior-authorization rules?
“Prior authorization” (PA) means your doctor has to prove to the plan that you medically qualify before it pays. Foundayo has its own PA checklist at CVS Caremark, and it’s specific. We break it down below — including the one rule that trips up people who’ve already lost weight.
What does my CVS Caremark Foundayo result mean? (NF, NPB, PA, QL)
When you look up Foundayo in your Caremark account, you may not see a simple “covered” or “not covered.” You’ll often see codes like NF, NPB, PA, or QL — and each one points to a different next step. Here’s the plain-English decoder, using CVS/Aetna’s own labels.
| Code | What it means | What it means for your Foundayo |
|---|---|---|
| PA | Prior authorization required | Your doctor must submit documentation before the plan pays |
| NF | Non-formulary (not on the covered list) | Not covered unless you win a formulary exception |
| NPB | Non-preferred brand | May be covered, but at a higher cost tier with more rules |
| QL | Quantity limit | The amount or refill timing is capped — see the 25-day/75-day windows in the PA section |
| ST | Step therapy | You may have to try a preferred drug (like Wegovy) first |
| PB | Preferred brand | The plan's favored option at a lower cost tier |
| "Drug not found" | Not listed yet, or you searched the wrong term | Search orforglipron too, and call — the list may not be updated yet |
A reality check on timing
Foundayo only cleared the coverage block on June 1, and these formularies refresh the first week of every month. You may see Foundayo as non-preferred, non-formulary, restricted with PA, or not listed yet — and one CVS Caremark member can see something completely different from another. Check your current plan, not an old screenshot.
How do I check whether my CVS Caremark plan covers Foundayo?
Check three places, in order: your Caremark account, CVS Caremark by phone, then HR — because the most common dealbreaker (a weight-loss exclusion) is one only HR can confirm. The goal is to tell apart a clinical denial (fixable with documents) from a plan exclusion (not fixable with an appeal).
Step 1 — Look it up.
Sign in at Caremark.com or the app and search both Foundayo and orforglipron. Screenshot whatever shows up — the status, the tier, any codes.
Step 2 — Call CVS Caremark.
Use the number on your card and ask, word for word:
"Is Foundayo — generic name orforglipron — on my plan's formulary today? What tier is it? Does it need prior authorization or step therapy? Is there a quantity limit? And if it's denied, would that be because of missing documentation, non-formulary status, or a plan exclusion?"
Step 3 — Ask HR the question CVS can't answer.
CVS Caremark runs the formulary, but your employer decides whether weight-loss drugs are covered at all. Ask:
"Does our prescription plan cover FDA-approved weight-loss medicines, including GLP-1 drugs? If not, is that exclusion part of the standard CVS Caremark plan, or did our company add it?"
Step 4 — Save everything.
Screenshots, reference numbers, the formulary result, and any denial letter. If you end up appealing, this is your evidence.
Skip the hold music — a free coverage check does this for you.
Ro contacts your plan and sends back a personalized coverage report.
See if your plan covers Foundayo — free → (sponsored affiliate link, opens in a new tab)Ro GLP-1 Coverage Checker — sponsored.
What are the CVS Caremark prior-authorization rules for Foundayo?
CVS Caremark’s Foundayo prior-authorization checklist requires a baseline BMI of 30 or higher (or 27+ with a weight-related condition), proof you’ve done a 6-month weight-management program, and — for refills — at least 5% weight loss. The single most important detail: if you switched from another weight-loss drug, the plan uses your BMI from when you first started treatment, not your lower BMI today. Source: CVS Caremark’s own Foundayo PA criteria, reference 7433-C, April 2026.
To get approved the first time, your doctor must document ALL of this:
A 6-month weight-management program that included behavioral changes, a reduced-calorie diet, and more physical activity, with follow-up — before starting the drug.
Baseline BMI ≥ 30, or Baseline BMI ≥ 27 plus at least one weight-related condition (high blood pressure, type 2 diabetes, or high cholesterol).
The drug is being used with a reduced-calorie diet and more physical activity (not on its own).
Foundayo isn't being combined with another GLP-1. CVS's criteria say combining it with Wegovy, Ozempic, or Zepbound is not recommended.
⚠️ The rule that catches people who already lost weight
If you’re switching from Zepbound, Wegovy, or another weight-loss drug and your BMI is lower now, CVS’s criteria say to use your baseline BMI at the start of any drug therapy — not your current number. Your doctor should document where you started, not where you are today. Miss this, and an otherwise-qualified person gets denied for a BMI that’s now “too low.” This one line, documented right, can be the difference between a clean approval and a preventable denial.
To keep your coverage (renewal), you’ll need:
More PA specifics worth knowing:
- •Quantity limits: 30 tablets per 25 days (one-month fill) and 90 tablets per 75 days (three-month fill). The shorter day counts are built in for refill processing.
- •First approval runs 8 months; renewals run 12 months at a time.
Got the documents? Let someone else handle the paperwork.
The prior-authorization paperwork is where people stall for weeks. Ro runs the free coverage check, and if a prior authorization is needed, Ro’s team submits the paperwork for you. That turns the most annoying step into something you don’t have to manage.
Honest catch: Ro isn’t free — there’s a membership on top of the medicine. Starts at $39 the first month, ongoing $149/month or as low as $74/month paid annually. If you’re paying cash and want the cheapest possible prescriber, our Foundayo cost guide lays those out. But for anyone trying to use insurance, Ro’s edge is exactly what’s hard about this drug — checking coverage and clearing the PA.
See if you qualify — let Ro handle the prior authorization → (sponsored affiliate link, opens in a new tab)Ro — sponsored, opens in a new tab.
How much does Foundayo cost with CVS Caremark — or without it?
If your commercial plan covers Foundayo and you use the savings card, you can pay as little as $25 a month. If your plan doesn’t cover it, self-pay runs about $149/month at the starter dose and rises to about $349 at the top dose. Your cost lands in one of four lanes.
Lane 1 — Covered commercial plan + savings card
As little as $25/monthThe Foundayo Savings Card takes the most off when your plan already covers the drug. Limits: up to $100 off a one-month fill, up to 10 fills a year, commercial insurance only — not Medicare, Medicaid, Part D, VA, DoD, or TRICARE. Manufacturer cards generally can't be reimbursed through HSA or FSA. Confirm current card terms since Lilly updates them. (Eli Lilly; Ro.)
Lane 2 — Medicare GLP-1 Bridge
$50/month flatFull details in the Medicare section below.
Lane 3 — Self-pay through LillyDirect or a telehealth platform
~$149–$349/monthDepends on dose — see the table below. Far better than retail pharmacy pricing.
Lane 4 — Regular pharmacy with no program
~$800+/monthNo coverage, no self-pay program. The most expensive route by far.
Self-pay dose breakdown — prices via Eli Lilly’s Foundayo self-pay program:
| Dose | Self-pay price (1 month) | Note |
|---|---|---|
| 0.8 mg | $149 | Starting dose |
| 2.5 mg | $199 | Titration |
| 5.5 mg | $299 | — |
| 9 mg | $299 | — |
| 14.5 mg | $349 | $299 if you refill within 45 days of last fill's delivery date |
| 17.2 mg | $349 | $299 if you refill within 45 days of last fill's delivery date |
The smart play: sort your coverage in month one or two, while you’re still on the cheaper starting dose and have time to clear prior authorization. Get it done early and you reach maintenance doses already in the $25 lane — not the $349 lane.
What if CVS Caremark denies or won’t cover Foundayo?
A denial isn’t one thing — the fix depends on why you got it. A missing-documents denial gets resubmitted; a non-formulary denial needs an exception; a plan exclusion usually can’t be appealed at all. Match your reason to the right step:
| Why you were denied | What it means | The document or step to request |
|---|---|---|
| Missing PA documentation | Plan may cover it, but the paperwork fell short | Resubmit with baseline BMI, your weight-related condition, and your 6-month program records |
| "Your BMI is too low" | Plan looked at your current BMI, not your starting one | Have your doctor document your baseline BMI at the start of therapy |
| Non-formulary (NF) | Foundayo isn't on your covered list | Request the plan's formulary-exception criteria and apply |
| Plan exclusion | Your employer doesn't cover weight-loss drugs | Ask HR about open enrollment; an appeal usually won't overturn this |
| Quantity limit (QL) | A refill amount or timing issue | Check the 25-day/75-day windows above; it's often just a timing fix |
| Step therapy (ST) | Plan wants a preferred drug tried first | Ask for the step-therapy rules and the exception process |
When to appeal
Documentation or medical-necessity denial: the plan is asking for proof, not saying no. Resubmit with the missing pieces.
When to stop fighting the PA
If HR confirms a true weight-loss-drug exclusion, your faster paths are open enrollment, a benefits escalation — or self-pay.
If coverage is a dead end, through LillyDirect or a telehealth platform self-pay Foundayo starts around $149/month — see your real options in our Foundayo cost guide.
Does Medicare with CVS Caremark cover Foundayo?
Not through regular Part D for weight loss — Medicare is legally barred from covering drugs used only to lose weight. But there’s a real path: the Medicare GLP-1 Bridge covers all Foundayo formulations at a flat $50/month from July 1, 2026 through December 31, 2027. This holds whether your Part D drug coverage runs through CVS Caremark or another PBM, because the Bridge sits outside normal Part D.
All Foundayo doses, all Wegovy forms (shot and pill), and only the KwikPen version of Zepbound. (CMS.)
A flat $50 a month, the same at every dose. That $50 doesn't count toward your Part D deductible or yearly out-of-pocket max, and low-income subsidies don't lower it further. You can't stack the savings card on top. (CMS.)
You must be in a Medicare Part D plan and meet specific BMI rules — BMI of 35+; or 30+ with heart failure, uncontrolled high blood pressure, or chronic kidney disease; or 27+ with prediabetes, a prior heart attack, a prior stroke, or symptomatic peripheral artery disease. (CMS.)
The program starts July 1, 2026. Confirm your BMI history now, but your prescriber can't submit the Bridge request until on or after July 1.
If you have type 2 diabetes, sleep apnea, or MASH, you can already get GLP-1s through regular Part D for those — which makes you ineligible for the Bridge, since it's for weight management only. (CMS.)
If you’re on Medicare and want Foundayo for weight loss, the Bridge — not your plan’s formulary — is your road in.
What if CVS Caremark covers Wegovy or Zepbound instead?
If your plan prefers Wegovy or Zepbound, you may have to try the preferred drug first (step therapy) or document why Foundayo is the better fit — and you should never add Foundayo on top of another GLP-1. Foundayo’s own label and CVS’s PA criteria both say combining it with another GLP-1 isn’t recommended.
Wegovy is preferred on your plan.
Expect possible step therapy. Your prescriber can request an exception if Wegovy isn't right for you. If you specifically want a pill, note that oral Wegovy has stricter timing (morning, empty stomach, wait before eating) than Foundayo, which you can take any time of day.
Zepbound coverage comes back.
CVS is adding Zepbound back as an additional preferred option on October 1, 2026 for plans that elect it. (CVS Health.) That can change your easiest-to-approve option — but it doesn't automatically change Foundayo's status.
You're maintaining after weight loss.
Circle back to the baseline-BMI rule above and make sure your doctor documents your starting point, not just today's number.
Is Foundayo FDA-approved, and who is it for?
Yes. The FDA approved Foundayo (orforglipron) on April 1, 2026, for adults with obesity, or adults who are overweight and have at least one weight-related condition, used together with a reduced-calorie diet and more activity. It’s the first small-molecule oral GLP-1 pill for weight management, taken once daily with or without food, with doses from 0.8 mg up to 17.2 mg. (FDA; Eli Lilly.)
A few things to take to your doctor — not medical advice, just what the label flags:
- •Foundayo carries a boxed warning (the FDA's strongest) about a thyroid tumor risk seen in animal studies, plus other contraindications.
- •The most common side effects are stomach-related (nausea, diarrhea, vomiting, constipation).
- •Warnings around pancreatitis, gallbladder problems, kidney injury, low blood sugar if combined with insulin or certain diabetes drugs, drug interactions, use in pregnancy, and birth-control timing.
This isn’t the complete safety list — read the Medication Guide and ask your clinician what applies to you. This page covers FDA-approved, brand-name Foundayo — not compounded versions of orforglipron.
Ro, LillyDirect, or your own doctor — which route is best?
It depends on where your friction is. If you already have a prescriber and just want the pill, LillyDirect is the cleanest. If you need help checking coverage and clearing prior authorization, Ro fits best here.
Ro — best if insurance and PA are your headache.
Ro offers Foundayo, runs a free coverage check, and its team submits the prior-authorization paperwork if it's needed. Self-pay on Ro starts at $149/month for the lowest dose (membership is separate, from $39 the first month). This is our primary pick for a coverage question because it solves the coverage and PA steps for you.
LillyDirect — best if you already have a prescription.
Eli Lilly's own direct channel and a straightforward way to fill at the self-pay prices above. No affiliate angle here — we mention it because it's the manufacturer-direct option.
Your own doctor — best if you have an established relationship.
A primary care doctor or obesity-medicine specialist can prescribe Foundayo and run the PA through your plan directly.
How we verified this (who, how, why)
The RX Index is a pricing intelligence and comparison resource for GLP-1 telehealth providers. This page was prepared by our editorial team using primary-source verification against CVS Health, CVS Caremark, CMS, Eli Lilly, the FDA, and Ro. No medical reviewer is listed because no medical reviewer reviewed it. Sources: CVS Health’s own announcement for the June 1, 2026 change; CVS Caremark’s Foundayo prior-authorization document (ref. 7433-C, April 2026) for the BMI and renewal rules; the June 1, 2026 CVS/Aetna plan drug guide for coverage-code definitions and weight-loss-exclusion language; CMS for the Medicare GLP-1 Bridge; Eli Lilly for savings-card terms and self-pay prices; and the FDA for approval and safety facts.
We keep three kinds of claims separate: verified commercial facts (prices, formulary rules, the savings card), medical and regulatory facts (FDA approval, Medicare law), and our own judgment (which route fits which reader). Last verified: .
Frequently asked questions
Does CVS Caremark cover Foundayo in 2026?
It can. CVS Caremark removed its new-to-market block on Foundayo effective June 1, 2026, so plans are now allowed to cover it. Whether your specific plan does depends on your employer's choices, whether your plan covers weight-loss drugs, and prior-authorization rules.
How much is Foundayo with CVS Caremark?
If your commercial plan covers it and you use the Foundayo Savings Card, as little as $25 a month. If it is not covered, expect self-pay of about $149 to $349 a month depending on your dose.
Does CVS Caremark require prior authorization for Foundayo?
Yes on the covered path. CVS Caremark's Foundayo criteria require a baseline BMI of 30 or higher, or 27 or higher with a weight-related condition, a documented 6-month weight-management program, and for renewals at least 5% weight loss. Your prescriber submits it.
Will CVS use my current BMI or my starting BMI for Foundayo?
For people switching from another weight-loss drug, CVS Caremark's criteria say to use your baseline BMI at the start of any drug therapy, not your lower current BMI. Your doctor should document where you started.
How long does CVS Caremark approve Foundayo for?
The first approval lasts 8 months and renewals last 12 months, based on CVS Caremark's Foundayo PA document. Renewal requires at least 3 months at a stable maintenance dose plus documented weight loss.
Is Foundayo preferred on CVS Caremark?
No. Wegovy is CVS Caremark's preferred GLP-1, and Zepbound returns as an additional preferred option October 1, 2026. Foundayo is newer and may sit as non-preferred or behind step therapy on some plans.
Can I use the Foundayo Savings Card with CVS Caremark?
Only if your CVS Caremark plan is commercial insurance. The card cannot be used with Medicare, Medicaid, TRICARE, or VA, and it works best when your plan already covers the drug.
Does Medicare with CVS Caremark cover Foundayo?
Not through normal Part D for weight loss. But the Medicare GLP-1 Bridge covers all Foundayo formulations at a flat $50 a month from July 1, 2026 through December 31, 2027 for eligible Part D members who meet the BMI rules.
What if my CVS Caremark plan denies Foundayo?
It depends on why. Resubmit a documentation denial with your baseline BMI and 6-month program, request an exception for a non-formulary denial, and check open enrollment if it is a plan exclusion. Self-pay of about $149 to $349 per month is a fallback that beats retail pricing.
Can I take Foundayo with Wegovy, Ozempic, or Zepbound?
No. Both the FDA label and CVS Caremark's criteria say using Foundayo with another GLP-1 is not recommended. Switching is a decision for your doctor.
Is this page medical advice?
No. It is an insurance and pricing guide. A licensed clinician decides whether Foundayo is right for you.
Still not sure which GLP-1 program is right for you?
Take our free 60-second matching quiz and get a personalized action plan based on your insurance, your budget, and whether you want a pill or a shot.
Get your personalized GLP-1 action plan →Sources
CVS Health (May 28, 2026 GLP-1 coverage announcement); CVS Caremark Foundayo Prior Authorization with Quantity Limit, ref. 7433-C (April 2026); 2026 CVS/Aetna Standard Control Plan Pharmacy Drug Guide (updated June 1, 2026); U.S. FDA / Eli Lilly (Foundayo approval, label, dosing); Eli Lilly — Foundayo Coverage & Savings; CMS — Medicare GLP-1 Bridge (beneficiary and provider pages); KFF; NPR; CNBC; Managed Healthcare Executive; Ro — GLP-1 Insurance Coverage Checker and Foundayo pages.
Re-verify pricing, formulary status, and Medicare Bridge dates before relying on them. Last verified: .